Revvity Inc (RVTY) - News Archive

Revvity’s Strategic Moves to Enhance Scientific Software and Genomic Diagnostics WALTHAM, Mass. In an ambitious bid to bolster its position in the analytical and genomic landscapes, Revvity, Inc. (NYSE: RVTY), has annou...

In the ever-evolving landscape of healthcare technology, Revvity, Inc. (NYSE: RVTY), headquartered in Waltham, Massachusetts, is set to make a noteworthy appearance at several prestigious investor conferences in the com...

Revvity s Latest Developments: Enhancing Precision in Healthcare WALTHAM, Mass. Revvity, Inc. (NYSE: RVTY) stands at the forefront of biotechnology innovation with a series of strategic advances aimed at enhancing the p...

Revvity Declares Quarterly Dividend: A Sign of Steady Progress in Health SciencesWALTHAM, Mass. In a notable development for investors and stakeholders alike, the Board of Directors of Revvity (NYSE: RVTY) announced tod...

From Virus Vigilance to Financial Resilience: Revvity s Dual Path of Innovation In an era where healthcare precision and profitability walk hand-in-hand, Revvity, Inc. (NYSE: RVTY) strides forward as a formidable player...

Revvity Inc. Announces Strategic Developments: Investor Day, New TB Testing Automation, and Upcoming Financial Call WALTHAM, Mass. Revvity, Inc. (NYSE: RVTY), a pioneering force in the biotechnological landscape, has an...

In a significant move for Alzheimer s disease management, Revvity, Inc. (NYSE: RVTY) has announced the launch of its groundbreaking in-vitro diagnostic tool, the EURORealTime™ APOE assay. This innovative assay, now avai...

In a recent press release, Revvity (NYSE: RVTY) announced its declaration of a regular quarterly dividend of $0.07 per share of common stock. This news comes amidst positive market performance, with Revvity Inc stock wi...

Revvity Unveils a New Era of Automated Tuberculosis TestingWALTHAM, Mass. - Revvity, Inc. (NYSE: RVTY) has recently introduced a groundbreaking development in tuberculosis testing with the launch of the Auto-Pure 2400 l...

Revvity, Inc. (NYSE: RVTY), based in Waltham, Massachusetts, is advancing its software and informatics division, Revvity Signals, with the introduction of two innovative software solutions - Signals SynergyTM and Signal...

Introducing Signals ChemDraw: Revolutionizing Chemistry Communication in the CloudWALTHAM, Mass. - Revvity, Inc. (NYSE: RVTY) is making waves once again in the field of chemical research and development with the launch...

Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven DecisionsWALTHAM, Mass. - Today, Revvity, Inc. (NYSE: RVTY) announced the launch of its cutting-e...

Revvity Strengthens its Board of Directors with Distinguished AppointmentsWALTHAM, Mass. - In a move aimed at bolstering its leadership and advancing its strategic goals, Revvity, Inc. (NYSE: RVTY) announced today the e...

Revvity, Inc. (NYSE: RVTY), a prominent player on the NYSE stage, has recently announced its intent to share the company s financial performance for the fourth quarter and the full year of 2023. Committed to maintaining...

At the close of trading on Wednesday, December 13, 2023, the stock market witnessed a significant surge, capturing the attention of investors worldwide. The uptrend was primarily fueled by impressive...

In a recent press release, Revvity (NYSE: RVTY) declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is set to be paid on February 9, 2024, to all shareholders of record as of January...